【Abstract】There are about 1,000,000～2,000,000 patients with end-stage renal disease (ESRD) in China, which consumes huge medical resources and results in great economic burden to the society. Peritoneal dialysis (PD) has the advantages of convenience, safe, effective and home treatment, becoming one of the alternative treatment methods suitable for ESRD patients in China. The number of registered PD patients increases nearly 20 times from 4,380 in 1999 to 86,264 by the end of 2018. With the improvement of dialysis registration system, the widespread utilization of standard PD operating protocols, and the increase of high- quality clinical studies on PD in China, we have achieved continuous advances in PD quality, large experiences in treatment and management of PD, and excellent reputations about the treatment of PD in the international community.